Kailera Therapeutics
CA - San DiegoBiotechnology
Focus: Kailera Therapeutics is a San Diego-based biotech focused on peptide and small molecule therapeutics for metabolic diseases, currently in mid-stage clinical development with a lead program in obesity.
Profile data last refreshed 47m ago · AI intelligence enriched 1mo ago
Open Jobs
23+5 this month
Growing — net +5 jobs in 30d
10 jobs added vs 5 removed. Steady team buildout.
Should You Work at Kailera Therapeutics?
AI assessmentStrong fit for clinical/operational roles seeking growth-stage biotech exposure to a hot therapeutic area, but limited security without approved product or disclosed cash position.
Why Work Here
- Active Phase 3 program (KAI-9531) in high-demand obesity indication with multiple trials across obesity and obesity-with-diabetes populations
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
KAI-9531
Healthy VolunteersClinical Trials (2)
NCT07458269Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Phase 2Help build intelligence for Kailera Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.